Psychiatrist and psychologist outline pharmacological and psychotherapeutic strategies for discontinuing antidepressants.
Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.
A JAMA Psychiatry study found links between PTSD, type 2 diabetes, and antidepressants.
First generation antipsychotics seem to cause general brain volume loss, while second generation antipsychotics seem to both increase and decrease the thickness of different parts of the brain.
Researchers from the Cochrane Center and University of Copenhagen in Denmark, publishing in the May issue of Addiction, "explore the rationale for claiming that...
Nora Volkow, the director of the National Institute on Drug Abuse (NIDA), authored an editorial for BMJ this month warning that the opioid abuse epidemic could have dangerous consequences for pregnant women. While the effects of opioid exposure on the developing brain are yet unknown, research suggests that infants may suffer from withdrawal syndrome, nervous system defects, and impaired attachment with the mother.
“Live, healthy babies are the most common outcome following the use of antipsychotic medication in pregnancy,” conclude Australian researchers in a study that was...
Two South African researchers review scientific understanding of the brain changes that lead to antidepressant discontinuation syndrome (ADS) in Human Psycho-pharmacology: Clinical and Experimental....
Study examines racial and ethnic disparities in the quality of care for Medicaid-enrolled children starting ADHD medication.
Ever higher levels of pharmaceutical drugs are turning up in drinking water supplies, and an op-ed in the UK Mirror discusses a study that...
Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.
German author and activist Peter Lehmann presents "Recovery by Taking Psychiatric Drugs versus Recovery by Coming Off of Psychiatric Drugs" at the 2012 International Society for Ethical Psychology and Psychiatry (ISEPP) Conference in Philadelphia, PA.
New research suggests that clinicians should exercise caution prescribing SNRIs as first-line treatment for mood and anxiety disorders.
Last year the British Medical Association (BMA) released a report on dependence and withdrawal from prescription drugs including benzodiazepines, z-drugs, opioids, and antidepressants. Now,...
The system that the US FDA is using to gather and report on information about dangerous side effects from medications is extremely unreliable and...
A scientific review says we need to know much more about the risks of nursing mothers taking SSRIs.
In her blog on USC Annenberg's Reporting on Health, journalist Martha Rosenberg reviews some of the quantitative evidence and qualitatively bizarre anecdotal evidence of...
New guidelines recommend deprescribing benzodiazepine receptor agonists for adults.
A new study explores how people manage to discontinue antipsychotic medication and examines how social supports may improve outcomes.
Greater cumulative doses of drugs that are anticholinergic or block the neurotransmitter acetylcholine are associated with significant increases in dementia and Alzheimer's.
Psychiatrists argue that current practice fails to account for the interaction of biological, psychosocial and iatrogenic factors.
Trials of antidepressants for relapse prevention are confounded by withdrawal effects caused by the drugs.
Neuroleptic Drugs and Violence by Catherine Clarke SRN, SCM, MSSCH, MBChA. and Jan Evans MCSP. Grad Dip Phys.
Depressed elderly people are more likely to suffer heart disease not because of their depression, but apparently due to antidepressant drugs.
Food and Drug Administration-approved information and public advertisements are misleading the public about the actual neurodegenerative risks from second-generation antipsychotics.